 SOUTH SAN FRANCISCO, Calif., Nov. 15, 2022 GLOBE NEWSWIRE -- Pliant Therapeutics, Inc. Nasdaq: PLRX, a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced participation in the following November investor conferences: 